December 25, 2014 2:00 PM ET

Biotechnology

Company Overview of Amulet Pharmaceuticals, Inc.

Company Overview

Amulet Pharmaceuticals, Inc., a biotechnology company, develops nitric oxide based technologies for safety of cardiovascular stents, medical devices, and drugs. Its nitric oxide technology and products are used in coronary and peripheral vascular drug eluting stents, implantable medical devices, wounds, diabetes therapeutics, pain therapeutics, glaucoma, and self-disinfecting contact lenses and cases. The company was founded in 2001 and is headquartered in Rockville, Maryland.

9430 Key West Avenue

Suite 120

Rockville, MD 20850

United States

Founded in 2001

Phone:

240-499-2740

Fax:

240-599-1193

Key Executives for Amulet Pharmaceuticals, Inc.

Chairman and Chief Executive Officer
Age: 55
Chief Financial Officer
Chief Operating Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Phloronol, Inc. United States
Advanced Pain Remedies, Inc. United States
Kuehnle Agrosystems, Inc. United States
Onconome, Inc. United States
BTI Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Amulet Pharmaceuticals, Inc., please visit www.amuletpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.